Survival Differences between Adolescents/Young Adults and Children with B Precursor Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 1, 2013, Pages 138-142

  Burke, Michael J ^a   Gossai, Nathan ^b   Wagner, John E ^a   Smith, Angela R ^a   Bachanova, Veronika ^a   Cao, Qing ^c   MacMillan, Margaret L ^a   Stefanski, Heather S ^a   Weisdorf, Daniel J ^a   Verneris, Michael R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Myeloablative; Relapse; Transplant related mortality

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA; CHILD; FEMALE; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; PRESCHOOL CHILD; RELAPSE; RISK FACTOR; SCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84871918387     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.08.020     Document Type: Article

References (32)

1. Pui C.H., Campana D., Pei D., et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009, 360:2730-2741.
2. Nachman J., Sather H.N., Gaynon P.S., et al. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group. J Clin Oncol 1997, 15:2222-2230.
3. Pui C.H., Sallan S., Relling M.V., et al. International Childhood Acute Lymphoblastic Leukemia Workshop: Sausalito, CA, 30 November-1 December 2000. Leukemia 2001, 15:707-715.
4. Smith M., Arthur D., Camitta B., et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996, 14:18-24.
5. Barry E., DeAngelo D.J., Neuberg D., et al. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol 2007, 25:813-819.
6. Freyer D.R., Devidas M., La M., et al. Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group. Blood 2011, 117:3010-3015.
7. Stock W., La M., Sanford B., et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood 2008, 112:1646-1654.
8. Stock W. Adolescents and young adults with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2010, 2010:21-29.
9. Larson S., Stock W. Progress in the treatment of adults with acute lymphoblastic leukemia. Curr Opin Hematol 2008, 15:400-407.
10. Festa R.S., Tamaroff M.H., Chasalow F., et al. Therapeutic adherence to oral medication regimens by adolescents with cancer, I: laboratory assessment. J Pediatr 1992, 120:807-811.
11. Landier W., Hughes C.B., Calvillo E.R., et al. A grounded theory of the process of adherence to oral chemotherapy in Hispanic and caucasian children and adolescents with acute lymphoblastic leukemia. J Pediatr Oncol Nurs 2011, 28:203-223.
12. Mullighan C.G., Su X., Zhang J., et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009, 360:470-480.
13. Mullighan C.G., Zhang J., Harvey R.C., et al. JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2009, 106:9414-9418.
14. Harvey R.C., Mullighan C.G., Chen I.M., et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood 2010, 115:5312-5321.
15. Harrison C.J. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol 2009, 144:147-156.
16. Shaw P.H., Boyiadzis M., Tawbi H., et al. Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions. Cancer 2012, 118(14):3614-3617.
17. Majhail N.S., Brazauskas R., Hassebroek A., et al. Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia. Biol Blood Marrow Transplant 2012, 18(6):861-873.
18. Cohen-Gogo S., Marioni G., Laurent S., et al. End of life care in adolescents and young adults with cancer: experience of the adolescent unit of the Institut Gustave Roussy. Eur J Cancer 2011, 47:2735-2741.
19. Pritchard S., Cuvelier G., Harlos M., et al. Palliative care in adolescents and young adults with cancer. Cancer 2011, 117:2323-2328.
20. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
21. Lin D.Y. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997, 16:901-910.
22. Chessells J.M. Relapsed lymphoblastic leukaemia in children: a continuing challenge. Br J Haematol 1998, 102:423-438.
23. Smith A.R., Baker K.S., Defor T.E., et al. Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors. Biol Blood Marrow Transplant 2009, 15:1086-1093.
24. Leung W., Campana D., Yang J., et al. High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood 2011, 118:223-230.
25. Beck J.C., Cao Q., Trotz B., et al. Allogeneic hematopoietic cell transplantation outcomes for children with B-precursor acute lymphoblastic leukemia and early or late BM relapse. Bone Marrow Transplant 2011, 46:950-955.
26. Borgmann A., Baumgarten E., Schmid H., et al. Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?. Bone Marrow Transplant 1997, 20:939-944.
27. Ko R.H., Ji L., Barnette P., et al. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study. J Clin Oncol 2010, 28:648-654.
28. Chessells J.M., Veys P., Kempski H., et al. Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia. Br J Haematol 2003, 123:396-405.
29. Saarinen-Pihkala U.M., Heilmann C., Winiarski J., et al. Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data. J Clin Oncol 2006, 24:5750-5762.
30. Dreyer Z.E., Dinndorf P.A., Camitta B., et al. Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group. J Clin Oncol 2011, 29:214-222.
31. Pui C.H., Gaynon P.S., Boyett J.M., et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002, 359:1909-1915.
32. Pui C.H., Chessells J.M., Camitta B., et al. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 2003, 17:700-706.